Literature DB >> 15825566

Histologic characterization of rat vocal fold scarring.

Tomoko Tateya1, Ichiro Tateya, Jin Ho Sohn, Diane M Bless.   

Abstract

This study aimed to clarify the characteristics of rat vocal fold scarring by examining the alteration of key components in the extracellular matrix: hyaluronic acid, collagen, and fibronectin. Under monitoring with a 1.9-mm-diameter telescope, unilateral vocal fold stripping was performed, and larynges were harvested at 2, 4, 8, and 12 weeks after operation. The vocal folds were histologically analyzed with Alcian blue stain, trichrome stain, and immunofluorescence of collagen type I, collagen type III, and fibronectin. The scarred vocal folds showed less hyaluronic acid and more collagen types I and III than did the controls at all time points. Type III was stable for 12 weeks, while type I declined until 8 weeks and thereafter remained unchanged. Fibronectin increased for 4 weeks and then decreased; it was close to the control level at 8 and 12 weeks. These results suggest that the tissue remodeling process in scarred vocal folds slows down around 2 months after wounding.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15825566     DOI: 10.1177/000348940511400303

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  56 in total

1.  E-cadherin and transglutaminase-1 epithelial barrier restoration precedes type IV collagen basement membrane reconstruction following vocal fold mucosal injury.

Authors:  Changying Ling; Jennifer L Raasch; Nathan V Welham
Journal:  Cells Tissues Organs       Date:  2010-10-20       Impact factor: 2.481

2.  Biosimulation of inflammation and healing in surgically injured vocal folds.

Authors:  Nicole Y K Li; Yoram Vodovotz; Patricia A Hebda; Katherine Verdolini Abbott
Journal:  Ann Otol Rhinol Laryngol       Date:  2010-06       Impact factor: 1.547

3.  An in vivo study of composite microgels based on hyaluronic acid and gelatin for the reconstruction of surgically injured rat vocal folds.

Authors:  Jiska M S Coppoolse; T G Van Kooten; Hossein K Heris; Luc Mongeau; Nicole Y K Li; Susan L Thibeault; Jacob Pitaro; Olubunmi Akinpelu; Sam J Daniel
Journal:  J Speech Lang Hear Res       Date:  2014-04-01       Impact factor: 2.297

4.  Dexamethasone Controlled Release on TGF-β1 Treated Vocal Fold Fibroblasts.

Authors:  Aaron M Kosinski; Jewel M Pothen; Alyssa Panitch; M Preeti Sivasankar
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-02-09       Impact factor: 1.547

Review 5.  A Review of Hyaluronic Acid and Hyaluronic Acid-based Hydrogels for Vocal Fold Tissue Engineering.

Authors:  Tanaya Walimbe; Alyssa Panitch; Preeti M Sivasankar
Journal:  J Voice       Date:  2017-03-02       Impact factor: 2.009

6.  Surgical method to create vocal fold injuries in mice.

Authors:  Masaru Yamashita; Diane M Bless; Nathan V Welham
Journal:  Ann Otol Rhinol Laryngol       Date:  2009-02       Impact factor: 1.547

7.  Microstructural and mechanical characterization of scarred vocal folds.

Authors:  Hossein K Heris; Amir K Miri; Nageswara R Ghattamaneni; Nicole Y K Li; Susan L Thibeault; Paul W Wiseman; Luc Mongeau
Journal:  J Biomech       Date:  2015-01-21       Impact factor: 2.712

8.  Microarray-driven validation of reference genes for quantitative real-time polymerase chain reaction in a rat vocal fold model of mucosal injury.

Authors:  Zhen Chang; Changying Ling; Masaru Yamashita; Nathan V Welham
Journal:  Anal Biochem       Date:  2010-07-27       Impact factor: 3.365

9.  Homeostasis of hyaluronic acid in normal and scarred vocal folds.

Authors:  Ichiro Tateya; Tomoko Tateya; Makoto Watanuki; Diane M Bless
Journal:  J Voice       Date:  2014-12-09       Impact factor: 2.009

10.  Alteration in cellular morphology, density and distribution in rat vocal fold mucosa following injury.

Authors:  Changying Ling; Masaru Yamashita; Emily A Waselchuk; Jennifer L Raasch; Diane M Bless; Nathan V Welham
Journal:  Wound Repair Regen       Date:  2009-12-11       Impact factor: 3.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.